Commercial Bancgroup, Inc. Common Stock
NASDAQ:CBKBanks
-$0.17 today
- Market cap
- $442.57M
- Beta
- 0.68
- P/E (TTM)
- 11.2
- EPS (TTM)
- $2.76
- Dividend yield
- 0.65%
Volume 0.03M
Average 0.06M
CBK Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Commercial Bancgroup, Inc. Common StockNASDAQ: CBK
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures dips below year-ago levels
Q1 FY2026 capital expenditures of $237.35K (cash outflow) fell 28.7% year over year, behind the +7.0% change in trailing-twelve-month capital expenditures. Sequentially, it fell 27.4% from the prior quarter.
Context
- Capital expenditures amounted to 1.4% of revenue in FY2025, down 0.9 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 2 fiscal years.
- FY2025 was the smallest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly growth recovers from -28.7% toward the trailing-twelve-month pace of +7.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (1.87M) USD
- Year-over-year change
- +38.7%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.87M) | +38.7% |
| FY2024 | 2024-12-31 | (3.04M) | +3.9% |
| FY2023 | 2023-12-31 | (3.17M) | — |
Capital Expenditures vs competitors
How CBK compares with its peers on the latest reported figures
- CBK's LTM Mar 2026 capital expenditures of $1.77M is the 6th largest of the 11 companies compared; the peer median is $2.37M.
- Its year-over-year change of +7.0% is the 6th highest of 11, against a peer median of +4.3%.
- Capital expenditures amounts to 1.4% of revenue for CBK, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $15.59M | +96.2% | +56.0% | 4.5% | |
| LTM Mar 2026 | $5.74M | +377.1% | +36.9% | 9.0% | |
HTBHomeTrust Bancshares, Inc. | LTM Mar 2026 | $4.42M | -72.1% | — | 1.5% |
| LTM Mar 2026 | $4.01M | +63.9% | +3.5% | 3.3% | |
| LTM Mar 2026 | $3.23M | -27.8% | +9.5% | 0.9% | |
| LTM Mar 2026 | $1.77M | +7.0% | — | 1.4% | |
| LTM Mar 2026 | $1.52M | +141.9% | -38.7% | 0.7% | |
| LTM Mar 2026 | $1.07M | -2.8% | -19.5% | 1.1% | |
| LTM Mar 2026 | $886K | -89.2% | +15.5% | 0.2% | |
| LTM Mar 2026 | $720K | +11.5% | -65.3% | 0.4% | |
| LTM Mar 2026 | $43K | -69.9% | -34.3% | 0.0% | |
| Peer median (excluding CBK) | $2.37M | +4.3% | +3.5% | 1.0% | |
Competitors are the stored peer set for CBK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | 31.21M | 31.69M | 37.2M |
| Depreciation & Amortization | 3.54M | 4.59M | 3.71M |
| Deferred Income Tax | 0 | 0 | (227.79K) |
| Stock-Based Compensation | 458.62K | 2.14M | 124.38K |
| Change in Working Capital | 336.39K | (704.72K) | (2.33M) |
| Accounts Receivables | (2M) | 1.05M | (263.74K) |
| Inventory | 0 | 0 | 0 |
| Accounts Payables | 2.88M | 1.17M | (1.26M) |
| Other Working Capital | (545.12K) | (2.93M) | (802.48K) |
| Other Non-Cash Items | 3.34M | 957.57K | (1.38M) |
| Operating Cash Flow | 38.89M | 38.68M | 37.09M |
| Capital Expenditures | (3.17M) | (3.04M) | (1.87M) |
| Acquisitions (Net) | 7.97M | 0 | 288.21K |
| Purchases of Investments | (16.65M) | (47.27M) | (134.95M) |
| Sales of Investments | 35.36M | 81.31M | 174.06M |
| Other Investing Activities | (151.47M) | (115.93M) | (70.2M) |
| Investing Cash Flow | (127.96M) | (84.93M) | (32.66M) |
| Debt Repayment | 6.68M | (40.69M) | 57.67M |
| Common Stock Issued | 3.89M | 0 | 29.86M |
| Common Stock Repurchased | (2.11M) | (1.83M) | (980.8K) |
| Dividends Paid | (1.5M) | (2M) | (2M) |
| Other Financing Activities | 176.13M | 113.03M | (122.86M) |
| Financing Cash Flow | 183.1M | 68.51M | (38.31M) |
| Effect of Forex Changes | 0 | 0 | 0 |
| Net Change in Cash | 94.03M | 22.26M | (33.88M) |
| Free Cash Flow | 35.72M | 35.63M | 35.23M |
Commercial Bancgroup, Inc. Common Stock
NASDAQ:CBK
Intrinsic Alpha fair value
Locked
Current Price
$32.28
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.